Filing Details
- Accession Number:
- 0001362118-23-000033
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-05-24 09:16:55
- Reporting Period:
- 2023-05-22
- Accepted Time:
- 2023-05-24 09:16:55
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
948320 | Lifemd Inc. | LFMD | Services-Offices & Clinics Of Doctors Of Medicine (8011) | 760238453 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1720512 | Justin Schreiber | 236 Fifth Avenue Suite 400 New York NY 10001 | Ceo | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, Par Value $0.01 | Acquisiton | 2023-05-22 | 17,664 | $2.15 | 2,812,284 | No | 4 | P | Direct | |
Common Stock, Par Value $0.01 | Acquisiton | 2023-05-23 | 32,336 | $2.06 | 2,844,620 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct |
Footnotes
- The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $2.13 to $2.16 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- Includes 2,794,620 shares previously reported as held indirectly which were distributed to the Reporting Person and are now held directly.
- The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $1.995 to $2.15 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.